Uro-Mag

Quick links to important sections

Uro-Mag

Treatment option:

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Uro-Mag

Quick Facts

Feature Detail
Active Ingredient Magnesium Oxide
Drug Class Mineral Supplement, Antacid, Laxative
Primary Use Magnesium deficiency (Hypomagnesemia)

Uro-Mag is a non-prescription (over-the-counter) medication whose primary active ingredient is magnesium oxide. Magnesium is an essential mineral that serves as a cofactor in over 300 enzyme systems, supporting vital functions such as muscle and nerve function, blood glucose control, and bone structure.

Uro-Mag is typically used to prevent or treat conditions related to low levels of magnesium in the blood (hypomagnesemia). A balanced diet usually provides adequate magnesium, but certain health conditions or medications (such as some diuretics) can lead to rapid magnesium loss, necessitating a supplement.

Because of the chemical properties of magnesium oxide, the product may also be utilized for other purposes, including as an antacid to relieve symptoms of acid indigestion, heartburn, or upset stomach, and as a saline laxative for the short-term relief of occasional constipation. Magnesium oxide may have lower bioavailability (absorption) compared to some other forms of magnesium, but it remains effective for its indicated uses.

Regulatory References

  1. Magnesium Oxide MedlinePlus

What side effects are possible with Uro-Mag?

Possible Side Effects and Safety Information

The safety profile for Uro-Mag (magnesium oxide) is structured around potential effects on the Gastrointestinal system and the rare, but serious, risk of systemic toxicity, as documented in official regulatory sources.

Adverse Reaction Scope

Category Details (Official Regulatory Documents)
Key Adverse Reaction Categories Gastrointestinal disorders and Immune system disorders. The most critical systemic risk is hypermagnesemia (high blood magnesium levels).
Frequency Classification Very Common: Diarrhea and soft stool, consistent with the compound's osmotic properties. Frequency Not Known: Hypersensitivity reactions, including pruritus (itching) and urticaria (hives/rash).
System-Organ Classes Involved Gastrointestinal disorders (diarrhea, cramping, nausea, vomiting) and Immune system disorders (hypersensitivity reactions).
Serious Adverse Reactions Hypermagnesemia: This condition is a serious documented risk that can manifest as irregular heartbeat, low blood pressure, confusion, slowed breathing, and in severe cases, coma and death.
Population-Specific Safety Considerations Individuals with kidney disease or renal dysfunction are at significantly increased risk of hypermagnesemia because magnesium excretion is impaired. Older adults and pregnant/breastfeeding individuals are advised to seek professional oversight prior to use.
Dose- or Exposure-Related Patterns The risk of serious hypermagnesemia is officially associated with long-term use or excessive doses of the medicine.
Safety-Related Restrictions Official labeling includes a major constraint against use in patients with severe kidney disease. Caution is also noted regarding the potential for interaction with certain prescription drugs.

Resulting Safety Structure

The most frequent official adverse effects are local Gastrointestinal disorders. The most severe risk, hypermagnesemia, is linked primarily to excessive exposure or use by individuals with the population-specific safety constraint of compromised renal function. This structure defines the boundary between common, expected effects and the serious, conditional systemic risks of the medicine.

Overdose and Emergency Response

Overdose and When to Seek Help

The documented clinical state resulting from an overdose of Uro-Mag (Magnesium Oxide) is known as hypermagnesemia, which is characterized by high levels of magnesium in the blood. Regulatory documentation describes a progression of symptoms from initial discomfort to severe, life-threatening complications. The manifestations are categorized based on physiological systems affected.

Documented Manifestations Severe Outcomes
Nausea, vomiting, diarrhea Respiratory paralysis or arrest
Lethargy, muscle weakness Cardiac arrhythmias, heart block
Loss of deep tendon reflexes Cardiac arrest, coma
Low blood pressure (hypotension) Profound confusion

Overdose risk is explicitly documented as being significantly higher for individuals with impaired kidney function (renal disease), who are unable to efficiently excrete excess magnesium, leading to rapid toxicity. The elderly population is also noted to face elevated risk.

When to Seek Urgent Medical Help: Government authorities mandate that patients or caregivers seek emergency medical attention immediately upon suspicion of overdose. Emergency services (911) must be called immediately if the person has collapsed, has trouble breathing, has had a seizure, or cannot be awakened. Management procedures documented in official sources include the immediate discontinuation of the medication, alongside procedural steps such as administering intravenous calcium gluconate to counteract severe effects, and potentially dialysis or diuretics to aid clearance.

Therapeutic Uses of Uro-Mag

What Uro-Mag Treats: Main Uses and Benefits

Uro-Mag is utilized across multiple areas of symptomatic support. It is commonly used to help with managing low magnesium levels (hypomagnesemia), symptomatic relief for acid indigestion and heartburn, and support for occasional or chronic functional constipation.

This medicine is applied in clinical settings that involve acute or unstable symptom patterns, particularly when symptoms are related to systemic imbalance or symptoms linked to organ-specific functional stress. It may assist with easing distressing manifestations such as muscle cramps, fatigue, and weakness, which are symptoms related to systemic imbalance. In the context of digestive relief, it helps manage symptoms related to episodic or fluctuating manifestations, contributing to easing the overall symptom load. This dual application provides supportive relief when symptoms interfere with routine activities, contributing to improved day-to-day comfort.

Quick Fact: Symptomatic Relief Domains
Uro-Mag is commonly used to address symptoms related to systemic imbalance (deficiency) and symptoms linked to organ-specific functional stress (digestive discomfort), offering supportive symptomatic assistance in both areas.

Regulatory References

  1. NIH MedlinePlus Drug Information on Magnesium Oxide

Eligibility and Restrictions for Use

Who Can and Cannot Use Uro-Mag?

The official eligibility profile for Uro-Mag (Magnesium Oxide) is defined by regulatory documents, outlining populations for whom use is permitted, restricted, or contraindicated.


Eligibility Scope

Eligibility Category Official Regulatory Classification
Populations for whom use is allowed Adults (18 years and older) for self-medication of labeled uses.
Populations for whom use is contraindicated Individuals with a known hypersensitivity to Magnesium Oxide or any inactive product ingredients.
Age-related eligibility rules Use is restricted in children, requiring medical advice before administration.
Condition-specific eligibility rules Use is restricted for patients with kidney disease (renal impairment), who must consult a health professional.
Pregnancy and lactation status Use is conditional; pregnant or breast-feeding individuals must consult a health professional.
Eligibility-related restrictions Use as a laxative is prohibited if acute symptoms like severe stomach pain, vomiting, or rectal bleeding are present.

Connection to the Overall Eligibility Profile

The regulatory framework establishes a single absolute contraindication based on hypersensitivity. For all other at-risk groups, including patients with kidney disease, children, and pregnant or breastfeeding individuals, the label applies mandatory restrictions that require consultation with a health professional prior to use.

What should I know about interactions with other medicines?

Interactions with other medicines and products

The official regulatory profile for Uro-Mag (magnesium oxide) is defined primarily by its capacity to interfere with the absorption of other oral medications and through additive physiologic effects. This information is derived from government regulatory documents, including FDA and NIH-aligned monographs.

Documented Pharmacokinetic and Pharmacodynamic Interactions

Interaction Type Interacting Agent Categories Outcome or Restriction
Reduced Absorption Quinolone/Tetracycline Antibiotics, Bisphosphonates, Integrase Inhibitors Significantly lowers the plasma concentration of the co-administered drug.
Additive Effect Calcium Channel Blockers, Muscle Relaxants Increased risk of hypotension or enhanced muscle relaxation.

Timing and Administration Constraints

To mitigate the effect of reduced absorption, the administration of certain drugs must be separated by specific time intervals. For example, official labeling mandates that Quinolone Antibiotics and Tetracycline Antibiotics should be administered at least two to six hours apart from Uro-Mag. Furthermore, co-administration with oral Phosphate Supplements or Levodopa/Carbidopa is officially restricted due to documented reduction in their effectiveness. For patients with renal dysfunction, the risk of systemic magnesium accumulation is heightened, which is a population-specific interaction consideration.

Mechanism of Action

Magnesium acts as a key cation, influencing multiple enzymatic and cellular processes, with primary mechanistic effects observed in neuromuscular and metabolic systems. ### Ion Channel and Neuromuscular ModulationMagnesium is a natural, non-competitive calcium channel modulator in excitable cells. By engaging this mechanism, it modifies molecular steps regulating the transmembrane influx of calcium ions. This action modulates Ca^2+ influx, resulting in decreased nerve excitability and promoting a shift toward the Mg^2+-dependent state of smooth muscle myocyte relaxation.### Enzyme Cofactor and ATP MetabolismThe mechanism involves Mg^2+ acting as an essential cofactor for over 300 enzymes. It supports the function of the ATP (adenosine triphosphate) complex by stabilizing the Mg^2+- ATP conformation. This facilitates pathway activity dependent on Mg^2+- ATP complex formation, influencing energy utilization and signal transduction cascades.### Gastrointestinal and Urologic HomeostasisIn the GI system, magnesium modulates water balance by increasing the osmotic pressure within the intestinal lumen. In the renal system, it affects urinary mineral saturation by modifying urinary composition, altering the saturation of Ca^2+ oxalate and influencing mineral precipitation kinetics.

Dosage and Administration Information

How to Use Uro-Mag (Magnesium Oxide) — Administration Guidelines

This information details the use and dosing instructions for Uro-Mag (Magnesium Oxide).

Administration Details

Usage Entity General Administration Details
Route of Administration Oral (by mouth).
Available Dosage Forms Capsule (e.g., 140 mg Magnesium Oxide) and Tablet.
Dosing Schedule Taken daily; may be taken as a single dose or divided into multiple doses.
Standard Dose Range For supplementation, 1 to 5 capsules daily, or 1 to 2 tablets daily. For antacid use, 1 tablet once or twice daily (e.g., 400 mg every 12 hours).

Proper Administration Conditions

To ensure proper intake and minimize gastrointestinal upset, observe the following conditions:

  • Food and Water: The medication should be taken with food and swallowed with a full glass of water (approximately 8 ounces or 240 mL). This is particularly important when used as a laxative.
  • Preparation: Do not crush, chew, or break the capsule or tablet. The dose must be swallowed whole.
  • Course Duration Limits: When using the maximum over-the-counter dose, do not continue use for more than two weeks for antacid purposes or seven days for laxative purposes without the direct instruction of a healthcare provider.

Population-Specific Rules

  • Adolescents (ge 12 years): Dosing for laxative use is 2 to 4 caplets daily, taken as a single or divided dose.
  • Kidney Health: Patients with existing kidney impairment require caution, and dose adjustments may be necessary.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Uro-Mag (Magnesium Oxide)


Evidence for use in Magnesium Deficiency (Hypomagnesemia)

Research exploring magnesium deficiency has primarily been conducted using Randomized Controlled Trials (RCTs) and systematic reviews. These studies were applied in research contexts involving fluctuating or unstable symptoms in adults who had confirmed low levels of magnesium in their blood. The studies monitored outcomes related to systemic or functional imbalance, specifically examining measured changes in magnesium concentration in the serum (a key biomarker).

Studies monitored measurements of deficiency-associated signs such as muscle cramps, weakness, and fatigue. Findings described patterns observed in the studies, including measurements of serum magnesium levels in subjects who received magnesium salts. However, certain pharmacokinetic studies focusing on absorption have described patterns indicating that the magnesium oxide form may have lower absorption (bioavailability) compared to some other types of magnesium salts used in supplementation protocols.

Evidence for use in Occasional and Chronic Constipation (Laxative Use)

The evidence for this use was evaluated in short-term RCTs and observational settings evaluating daily-life functioning in adult populations. The research examined outcomes reflecting daily functioning or activity level, primarily focusing on measurements like the frequency of spontaneous bowel movements and changes in stool consistency, as described by patient-reported outcomes.

Clinical trials documented measurements of bowel movement frequency and stool consistency observed during the defined time intervals. Studies documented that measurements of efficacy were observed to be lower when subjects were also taking medications that suppress gastric acid. This finding contributes to understanding symptom patterns and the variability of observed outcomes.


Long-term Studies and Follow-up Duration

Across all indications, research exploring short-term symptom changes is more commonly available than evidence derived from extended follow-up periods. Long-term effects are not fully established regarding the sustained maintenance of magnesium levels in the body over many months or years. Evidence is limited regarding the effects of continuous use over extended time frames.

What is Still Uncertain About Uro-Mag

One key limitation is that evidence quality varies across studies, and findings were mixed regarding the comparative characteristics of magnesium oxide versus other magnesium compounds. The follow-up durations were limited in many clinical studies, and the available data provide limited insight into how symptoms evolve in the long term.

Key Studies & References

  1. Magnesium Oxide: MedlinePlus Drug Information

Frequently Asked Questions (FAQ)

Common questions about Uro-Mag (FAQ)


Q: Is Uro-Mag the same as a regular magnesium supplement?

Uro-Mag's active ingredient is magnesium oxide. Official regulatory documents indicate that magnesium oxide is classified as both a mineral supplement and an over-the-counter (OTC) drug. This dual classification exists because it is used for mineral supplementation but also has approved uses as an antacid and a saline laxative.

Q: Are there any specific vitamins or minerals that shouldn't be taken with Uro-Mag?

According to official interaction data, magnesium oxide can interfere with the absorption of certain minerals. For example, co-administration with oral phosphate supplements is officially restricted. Also, some evidence suggests that taking high doses of calcium or zinc close to Uro-Mag may reduce the absorption or levels of magnesium in the body.

Q: Why is Uro-Mag sold as a medical product instead of just a diet supplement?

Uro-Mag is classified as a medical product due to the multiple approved purposes of its active ingredient, magnesium oxide. Official labeling reflects its uses as a dietary mineral supplement, an over-the-counter antacid, and a saline laxative. This breadth of documented uses under regulatory authority distinguishes it from products marketed only for dietary purposes.

Q: Are there reports of long-term users experiencing different side effects?

Official product safety information indicates that the risk of the most serious documented side effect, hypermagnesemia (abnormally high magnesium levels), is associated with long-term use or excessive doses. This risk is notably higher in individuals with impaired kidney function.

Q: What is the typical duration of use for Uro-Mag?

The duration of use is constrained by regulatory labeling for over-the-counter (OTC) use. When used as an antacid, the maximum recommended duration is two weeks. For use as a laxative, the maximum duration is seven days. Both durations are limited unless a healthcare professional instructs otherwise.

Q: What is the difference between Uro-Mag and Mag-Ox?

Uro-Mag and Mag-Ox are both brand names for medications containing the exact same active ingredient: magnesium oxide. Official regulatory dosing and usage information applies uniformly to the magnesium oxide ingredient, regardless of the specific brand name.

Q: What happens if I miss a dose of Uro-Mag?

Official patient guidance indicates that a missed dose may be taken as soon as it is remembered. However, if it is nearly time for the next scheduled dose, regulatory guidance describes skipping the missed dose. Product information describes the need to avoid taking a double dose to make up for a missed one.

Q: Does taking Uro-Mag make you tired or sleepy?

Drowsiness or severe drowsiness is not listed as a common expected side effect of Uro-Mag. However, official safety documentation indicates that these symptoms can be a sign of hypermagnesemia (high blood magnesium levels). Hypermagnesemia is a serious, documented risk associated with excessive doses of the medicine.

Q: Do any foods or drinks interact with Uro-Mag?

No specific food or drink interactions are listed in official product labeling. Instead of a direct interaction, administration guidelines describe taking the medication with food and a full glass of water. This is primarily done to help reduce common gastrointestinal side effects like stomach upset and diarrhea.

Q: Is Uro-Mag gluten-free or suitable for people with celiac disease?

Some official formulations of magnesium oxide are officially labeled as gluten-free in their regulatory information. Because inactive ingredients can vary by manufacturer and specific product, Official patient guidance describes the need to review the full list of inactive ingredients on the product label.

Q: Can Uro-Mag be taken at the same time as my thyroid medication?

Official interaction warnings describe that taking Uro-Mag close to thyroid medication (like levothyroxine) can interfere with the thyroid drug's absorption and reduce its effectiveness. Regulatory guidance requires the separation of the administration of the two medications by at least four hours to mitigate this effect.

Q: Does Uro-Mag require any special monitoring by a doctor?

Yes, according to official guidance, if a doctor has directed the use of this medication, periodic laboratory or medical tests may be performed. These tests, which can include magnesium blood levels and kidney function tests, are used to monitor the patient's progress and check for potential side effects.

Q: Can Uro-Mag be taken with antacids?

Uro-Mag is itself a magnesium-based antacid. Regulatory caution describes avoiding its use with other antacids (such as those containing calcium or aluminum) without professional consultation. This is to avoid potential additive effects or risks associated with taking multiple similar products.

Q: Is the absorption rate of Uro-Mag affected by food?

Official patient guidance indicates that taking Uro-Mag with food is generally described as beneficial. This practice not only helps reduce the chances of common stomach upset and diarrhea but also assists in increasing the absorption of the mineral into the body.

Q: Does Uro-Mag contain any common allergens?

Official product labeling is required to list all inactive ingredients, which may include substances like microcrystalline cellulose and magnesium stearate. For individuals with known allergies, product information describes the importance of reviewing the full list of inactive ingredients on the product label or consulting a healthcare professional to confirm suitability.

How should Uro-Mag be stored and disposed of?

How to Store and Dispose of Uro-Mag?

Official regulatory guidelines define strict conditions for the storage and disposal of Uro-Mag (Magnesium Oxide) to maintain product stability and protect public safety.

Storage & Disposal Rule Requirement
Storage Temperature Store at controlled room temperature, specifically 15 C to 30 C (59 F to 86 F).
Environmental Protection Keep the container tightly closed and store in a dry place away from excess heat and moisture (e.g., not in the bathroom).
Child Safety The medication must be kept out of the sight and reach of children at all times.
Disposal Instructions Do not flush unused or expired product down the toilet or pour into a drain. The preferred disposal method is a drug take-back program.
Alternative Disposal If a take-back option is unavailable, the product must be mixed with an undesirable substance (like coffee grounds), sealed in a container, and thrown into household trash.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Uro-Mag found in:

A-Z Index: